http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
오늘 본 자료
Islam in Southeast Asia and the Characteristics of Muslims in Indonesia
Ju San Yuan 한국이슬람학회 1994 한국이슬람학회논총 Vol.4 No.1
Islam is one of the three biggest religions in the world nowdays together with the Christian ity and Buddhism. It is more influencial than the two others. More and more scholars pay attention to the studies on Islam. Many of international affairs could not be separated with the Muslims in Africa and in Asia as well. In Southeast Asia, Islam also occupies an important position in people's life. In Malaysia, Indonesia, Brunei and the Southern part of Phillipine, there are wide Muslim communities. In this paper, I would like to touch 4 subjects as follows : 1.When did the Islam come to Southeast Asia? 2.Where did the Islam come from to Southeast Asia? 3.How did the Islam come to Southeast Asia? 4.What are the Characteristics of Muslims in Indonesia?
거삼원 한국이슬람학회 1994 한국이슬람학회논총 Vol.4 No.1
Islam is one of the three biggest religions in the world nowdays together with the Christian ity and Buddhism. It is more influencial than the two others. More and more scholars pay attention to the studies on Islam. Many of international affairs could not be separated with the Muslims in Africa and in Asia as well. In Southeast Asia, Islam also occupies an important position in people's life. In Malaysia, Indonesia, Brunei and the Southern part of Phillipine, there are wide Muslim communities. In this paper, I would like to touch 4 subjects as follows : 1.When did the Islam come to Southeast Asia? 2.Where did the Islam come from to Southeast Asia? 3.How did the Islam come to Southeast Asia? 4.What are the Characteristics of Muslims in Indonesia?
Chien-An Chen,Chun-Ju Chiang,Yun-Yuan Chen,San-Lin You,Shu-Feng Hsieh,Chao-Hsiun Tang,Wen-Fang Cheng 대한부인종양학회 2018 Journal of Gynecologic Oncology Vol.29 No.1
Objective: Adjuvant chemotherapy was introduced in patients with early-stage ovarian cancer (OC). The benefit of standard chemotherapeutic regimens including taxane has not been established. Methods: Patients with early-stage OC from the National Health Insurance Research database of Taiwan who received platinum plus cyclophosphamide (CP) or platinum plus paclitaxel (PT) for 3–6 cycles were recruited, and the disease-free survival (DFS) and overall survival (OS) were determined. Results: A total of 1,510 early-stage OC patients, including 841 who received CP regimen and 699 who received PT regimen, were included. The 2 groups had a similar estimated probability of 5-year DFS (PT vs. CP, 79.0% vs. 77.6%; p=0.410) and OS (84.6% vs. 84.3%; p=0.691). Patients >50 years of age who received the CP regimen had a lower 5-year DFS than the patients ≤50 years of age who received the CP (p<0.001) or PT regimens (p=0.001). Additionally, patients >50 years of age who received the CP regimen had a worse 5-year OS compared with the other 3 groups (p=0.019) (p=0.179 for patients >50 years of age in the PT group; p=0.002 for patients ≤50 years of age in the CP group; and p=0.061 for patients ≤50 years of age in the PT group). Patients with the CP or PT regimen for 3–5 cycles had a similar 5-year DFS and OS compared to 6 cycles (p>0.050). Conclusion: Chemotherapeutic regimens with taxane could be recommended for early-stage OC patients >50 years of age.
Yi-Jou Tai,Yun-Yuan Chen,Huang-Cheng Hsu,Chun-Ju Chiang,San-Lin You,Chi-An Chen,Wen-Fang Cheng,Taiwan Cervical Cancer Control Task Force 대한부인종양학회 2018 Journal of Gynecologic Oncology Vol.29 No.4
OBJECTIVE: To investigate the progression risk of atypical squamous cells of undetermined significance (ASCUS) with different clinical managements. METHODS: Women with their first diagnosis of ASCUS cytology were retrieved from the national cervical cancer screening database and linked to the national health insurance research database to identify the management of these women. The incidences of developing cervical intraepithelial neoplasia grade 3 and invasive cervical cancer (CIN3+) were calculated, and the hazard ratios (HRs) were estimated using a Cox proportional hazards model. This study was approved by the Research Ethics Committee of the National Taiwan University Hospital and is registered at ClinicalTrials.gov (Identifier: NCT02063152). RESULTS: There were total 69,741 women included. Various management strategies including colposcopy, cervical biopsies and/or endocervical curettage, and cryotherapy, failed to reduce the risk of subsequent CIN3+ compared with repeat cervical smears. Loop electrosurgical excision procedure/conization significantly decreased risk of subsequent CIN3+ lesions (HR=0.22; 95% confidence interval [CI]=0.07–0.68; p=0.010). Women in their 40s–50s had an approximately 30% risk reduction compared to other age groups. Women with a previous screening history >5 years from the present ASCUS diagnosis were at increased risk for CIN3+ (HR=1.24; 95% CI=1.03–1.49; p=0.020). CONCLUSION: In women of first-time ASCUS cytology, a program of repeat cytology can be an acceptable clinical option in low-resource settings. Caution should be taken especially in women with remote cervical screening history more than 5 years.